Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors.
Beetham H, Griffith BGC, Murina O, Loftus AEP, Parry DA, Temps C, Culley J, Muir M, Unciti-Broceta A, Sims AH, Byron A, Brunton VG.
Beetham H, et al. Among authors: muir m.
Cancer Res. 2022 Feb 15;82(4):632-647. doi: 10.1158/0008-5472.CAN-21-0373.
Cancer Res. 2022.
PMID: 34921014
Free PMC article.